Macro Outlook for Next Week: CPI and PPI Data Incoming, Pro-Crypto Fed Governor May Take Office
BlockBeats News, August 9 — The key macroeconomic data and events scheduled for release next week are as follows:
Tuesday:
US July CPI data;
2027 FOMC voting member and Richmond Fed President Thomas Barkin to deliver a speech.
Thursday:
Chicago Fed President Austan Goolsbee to speak on monetary policy;
Atlanta Fed President Raphael Bostic to discuss the US economic outlook;
US initial jobless claims for the week ending August 9 and August PPI data.
Friday:
US July retail sales month-on-month, July import price index month-on-month;
US preliminary one-year inflation expectations for August and preliminary University of Michigan Consumer Sentiment Index for August.
In addition, former President Trump has announced the nomination of “pro-crypto” official Stephen Miran as a Federal Reserve Board Governor, with a term ending January 31, 2026. Public information shows that during his tenure as Chair of the White House Council of Economic Advisers, he explicitly supported the Trump administration’s crypto-friendly policies. He believes cryptocurrencies have the potential to stimulate economic growth, drive financial innovation, and combat inflation, especially in the context of Trump’s economic agenda. However, the nomination still requires Senate approval.
Next week, traders will be closely watching the July CPI and PPI data releases on Tuesday and Thursday, as well as Friday’s retail sales data and the preliminary August University of Michigan Consumer Sentiment report. Even before the effects of reciprocal tariffs come into play, higher-than-expected inflation data could prompt traders to scale back bets on rate cuts.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
British Pound: Wider trading range expected against US Dollar – UOB
British Pound holds gains as UK GDP and Industrial Production beat expectations
UBS: Resumes coverage of Regeneron Pharmaceuticals (REGN.US) with a "Buy" rating; potential of blockbuster drug Dupixent underestimated
UBS has resumed coverage of Regeneron Pharmaceuticals (REGN.US) with a "Buy" rating and a target price of $978.
IMF sounds the alarm: Energy shocks and rising US Treasury yields pose spillover risks, Asia’s growth may slow to 4.4% next year
The IMF has lowered its growth forecast for Asia to 4.4% for next year, warning of three major risks: energy shocks, a correction in the AI boom, and rising global yields. The IMF also urged central banks to focus on price stability and avoid broad-based fuel subsidies.
Crypto prices
More
